1373 related articles for article (PubMed ID: 11473047)
1. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
[TBL] [Abstract][Full Text] [Related]
2. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
3. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
[TBL] [Abstract][Full Text] [Related]
4. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
5. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
6. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
Bugianesi E; Gastaldelli A; Vanni E; Gambino R; Cassader M; Baldi S; Ponti V; Pagano G; Ferrannini E; Rizzetto M
Diabetologia; 2005 Apr; 48(4):634-42. PubMed ID: 15747110
[TBL] [Abstract][Full Text] [Related]
8. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
Lewis GF; Vranic M; Harley P; Giacca A
Diabetes; 1997 Jul; 46(7):1111-9. PubMed ID: 9200644
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
11. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
12. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
[TBL] [Abstract][Full Text] [Related]
14. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Koopmans SJ; Kushwaha RS; DeFronzo RA
Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
[TBL] [Abstract][Full Text] [Related]
16. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
Vestergaard H; Parving HH; Hansen L; Pedersen O
Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
[TBL] [Abstract][Full Text] [Related]
17. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
Bugianesi E; Pagotto U; Manini R; Vanni E; Gastaldelli A; de Iasio R; Gentilcore E; Natale S; Cassader M; Rizzetto M; Pasquali R; Marchesini G
J Clin Endocrinol Metab; 2005 Jun; 90(6):3498-504. PubMed ID: 15797948
[TBL] [Abstract][Full Text] [Related]
18. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
[TBL] [Abstract][Full Text] [Related]
19. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty.
Arslanian SA; Kalhan SC
Diabetes; 1994 Jul; 43(7):908-14. PubMed ID: 8013756
[TBL] [Abstract][Full Text] [Related]
20. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
